Literature DB >> 1447578

Suppression of experimental autoimmune encephalomyelitis by a new specific leukotriene biosynthesis inhibitor.

I S Neu, J Mallinger, A Wildfeuer, L Mehlber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1447578     DOI： 10.1007/bf00856815

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  4 in total

Review 1.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

Authors:  B Samuelsson; S E Dahlén; J A Lindgren; C A Rouzer; C N Serhan
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

2.  Suppression of experimental autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition.

Authors:  M Prosiegel; I Neu; J Mallinger; A Wildfeuer; L Mehlber; S Vogl; G Hoffmann; G Ruhenstroth-Bauer
Journal:  Acta Neurol Scand       Date:  1989-03       Impact factor: 3.209

3.  Suppression of experimental autoimmune encephalomyelitis by sulfasalazine.

Authors:  M Prosiegel; I Neu; G Ruhenstroth-Bauer; G Hoffmann; S Vogl; L Mehlber; A Wildfeuer
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

4.  Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rats.

Authors:  K L Black; J T Hoff
Journal:  Ann Neurol       Date:  1985-09       Impact factor: 10.422
  4 in total
  1 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.